Gilead Sciences, Inc. (GILD) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $72.46, down from yesterday’s close by -0.50%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental AnalysisNo amount of research is complete without a bird’s eye view of the financial data. Gilead Sciences, Inc. (GILD) currently trades with a market capitalization of $95.09 Billion. That value represents a market adjusting for revenues that have been falling by -13.17 % on a quarterly year/year basis as of the company’s last quarterly report.
     (adsbygoogle = window.adsbygoogle || []).push({});
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For GILD, the company currently has $11.51 Billion of cash on the books, which is offset by $1.75 Billion current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $12.1 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.69 on a per share basis this quarter. Perhaps, that suggests something about why 76.60% of the outstanding share supply is held by institutional investors.Technical AnalysisIt’s important to check the technicals to get a sense of how GILD has been acting. Looking at the stock’s movement on the chart, Gilead Sciences, Inc. recorded a 52-week high of $86.27. It is now trading 13.81% off that level. The stock is trading $78.43 its 50-day moving average by 5.97%. The stock carved out a 52-week low down at $63.76.In recent action, Gilead Sciences, Inc. (GILD) has made a move of -6.96% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 17.96, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.51% with $1.30 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of GILD.